We Value Your Privacy

We use technology such as cookies on our website, and through our partners, to personalize content and ads, provide social media features, and analyse our traffic. To find out more, read our privacy policy and Cookie Policy. Please also see our Terms and Conditions of Use. By accepting these terms you agree to your information being processed by Inbox Insight, its Partners or future partners, that you are over 18, and may receive relevant communications through this website, phone, email and digital marketing. For more information on how we process your data, or to opt out, please read our privacy policy. Our policies and partners are subject to change so please check back regularly to stay up to date with our terms of use and processing.

Accept Terms Settings
x

Please Sign-In to Access this Report

To access other reports on the platform please sign in with your username and password, or register for a free account to get unlimited access and insight customized for you.

Report Hamilton CapTel

Hearing Loss and Comorbidities: 2022 Update

In 2017, Harvey Abrams, Ph.D., published a white paper examining specific chronic conditions associated with hearing loss titled Hearing Loss and Associated Comorbidities: What Do We Know? This new white paper from 2022 expands on the first one, exploring current associations between hearing loss and multiple other issues including fall risk, depression, social isolation, cognitive impairment and more. One topic not addressed in the 2017 paper – but added to this review – is the discussion associated with the combined effects of hearing and visual impairment, or dual sensory impairment (DSI). This paper also provides an update of the literature associated with the potentially modifying effects of audiologic intervention – specifically hearing aids.

Report Snap Shot

Read it to learn more about:

  • Statistical prevalence of the different comorbidities to hearing loss
  • Demographic breakdowns of the various comorbidities
  • Data associated with hearing loss treatment and comorbidity abatement

Related Content